Grant McFadden

24.2k citations

347 papers · 18.9k indexed · 3 hit papers · h-index 72

Impact in

Virology top 0.05%
- Poxvirus research and outbreaks
Immunology top 0.2%
- interferon and immune responses
- Immunotherapy and Immune Responses

Papers in

Virology 131
- Poxvirus research and outbreaks 129
Genetics 203
- Virus-based gene therapy research 197

Co-authors: Chris Upton Masmudur M. Rahman John W. Barrett Morgan Sheng Helen Everett Michael E. Greenberg B. Brett Finlay Karen Mossman
Journals: Journal of Virology (48 papers)Virology (45 papers)Journal of Biological Chemistry (11 papers)Proceedings of the National Academy of Sciences (11 papers)PLoS ONE (8 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Grant McFadden

342 papers receiving 18.6k citations

Hit Papers

align trajectories log scale

Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens 2006 · 651 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Cell
2003 Annual Review of Immunology
1990 Neuron

Peers

Countries citing papers authored by Grant McFadden

Since Specialization

Citations

This map shows the geographic impact of Grant McFadden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant McFadden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant McFadden more than expected).

Fields of papers citing papers by Grant McFadden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant McFadden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant McFadden. The network helps show where Grant McFadden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Grant McFadden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Grant McFadden Line = papers co-authored together Grant McFadden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator Biomedicines ·Algorithmic Algebras, Zehra SENÖZ, Ang Beng Ti, 笹山卓真, Ganesh Munuswamy‐Ramanujam, Alan Rawls, Jeanne Wilson‐Rawls, Hao Chen, Grant McFadden, Alexandra Lucas	2024	19
2	Adipose-Derived Stem Cells as Carrier of Pro-Apoptotic Oncolytic Myxoma Virus: To Cross the Blood–Brain Barrier and Treat Murine Glioma International Journal of Molecular Sciences ·Joanna Jazowiecka-Rakus, Maria Francisca da Costa Santiago, Masmudur M. Rahman, Grant McFadden, Aleksander Sochanik	2024	2
3	Nuclear Export Inhibitor Selinexor Enhances Oncolytic Myxoma Virus Therapy against Cancer Cancer Research Communications ·Masmudur M. Rahman, Sai Prathibha B S, Suma U. S, 髙宣京極, 许湘湘, Letícia Gonçalves Pereira, Kefilwe Rammutloa, 徹長尾, Jacquelyn Kilbourne, Nataya Devyaterikova, Timothy L. Karr, Grant McFadden	2023	3
4	Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic Osteosarcoma Cancers ·John D. Christie, Nicole Appel, Liqiang Zhang, 徹長尾, Jacquelyn Kilbourne, Nataya Devyaterikova, Katarina Mpofu, Alexandra Lucas, Joseph N. Blattman, Masmudur M. Rahman, Grant McFadden	2022	8
5	Combination of LIGHT (TNFSF14)-Armed Myxoma Virus Pre-Loaded into ADSCs and Gemcitabine in the Treatment of Experimental Orthotopic Murine Pancreatic Adenocarcinoma Cancers ·Joanna Jazowiecka-Rakus, Aleksander Sochanik, 朱莉·哈珀【美, 久保田潔, Ewa Chmielik, Masmudur M. Rahman, Grant McFadden	2022	6
6	Myxoma Virus Expressing LIGHT (TNFSF14) Pre-Loaded into Adipose-Derived Mesenchymal Stem Cells Is Effective Treatment for Murine Pancreatic Adenocarcinoma Cancers ·Joanna Jazowiecka-Rakus, 朱莉·哈珀【美, Masmudur M. Rahman, Grant McFadden, 久保田潔, Ewa Chmielik, Dave Harold Mbiazi Njanda, Jin-Yu He, Violetta Kozik, Aleksander Sochanik	2021	17
7	Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma Clinical Cancer Research ·RodriguezGerman, Zong Sheng Guo, David L. Bartlett, Ying Deng, Achyut Telang, Diana Thomas, Jia Liu, Grant McFadden, Joanna L. Shisler, Edward J. Roy	2020	44
8	A Virus-Derived Immune Modulating Serpin Accelerates Wound Closure with Improved Collagen Remodeling Journal of Clinical Medicine ·Mykola Zhulynskyi, Jordan R. Yaron, Wangliang Yan, Sarah E. Wallace, Jacquelyn Kilbourne, Shelley E. Haydel, Kaushal Rege, Grant McFadden, Alexandra Lucas	2019	20
9	Oncolytic Virus-Mediated RAS Targeting in Rhabdomyosarcoma Molecular Therapy — Oncolytics ·Michael Phelps, Владимир Алексеевич Кокшенев, Shivani Patel, Masmudur M. Rahman, Grant McFadden, Eleanor Y. Chen	2018	27
10	Crystal Structure of Cleaved Serp-1, a Myxomavirus-Derived Immune Modulating Serpin: Structural Design of Serpin Reactive Center Loop Peptides with Improved Therapeutic Function Biochemistry ·Brian P. Mahon, Sriram Ambadapadi, Jordan R. Yaron, Carrie L. Lomelino, Melissa A. Pinard, Shahar Keinan, Igor V. Kurnikov, Colin Macaulay, Liqiang Zhang, Westley H. Reeves, Grant McFadden, Scott A. Tibbetts, Robert McKenna, Alexandra Lucas	2017	20
11	Myxoma virus suppresses proliferation of activated T lymphocytes yet permits oncolytic virus transfer to cancer cells Blood ·Nancy Villa, Clive Wasserfall, Amy Meacham, Elizabeth Wise, Winnie Chan, John R. Wingard, Grant McFadden, Christopher R. Cogle	2015	33
12	Cellular Factors Promoting Resistance to Effective Treatment of Glioma with Oncolytic Myxoma Virus Cancer Research ·Franz J. Zemp, Brienne McKenzie, Xueqing Lun, Karlyne M. Reilly, Grant McFadden, V. Wee Yong, Peter Forsyth	2014	28
13	Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin Cancer Research ·C V Kruthik, Tommy Alain, Franz J. Zemp, Hongyuan Zhou, Masmudur M. Rahman, Mark G. Hamilton, Grant McFadden, John C. Bell, Donna L. Senger, Peter Forsyth	2010	89
14	Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors Clinical Cancer Research ·Nancy Esperanza Cano Cubillos, Xueqing Lun, Hongyuan Zhou, Limei Wang, Beichen Sun, John C. Bell, John W. Barrett, Grant McFadden, Jaclyn A. Biegel, Donna L. Senger, Peter Forsyth	2008	46
15	Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin Cancer Research ·A. Gregg Parsons, Hongyuan Zhou, Tommy Alain, Beichen Sun, Limei Wang, John W. Barrett, Marianne M. Stanford, Grant McFadden, John C. Bell, Donna L. Senger, Peter Forsyth	2007	88
16	Prevention of Chronic Renal Allograft Rejection by SERP-1 Protein Transplantation ·Eric L.R. Bédard, Jifu Jiang, Jacqueline Arp, Qian Hua, Hao Wang, Haiyan Guan, Liying Liu, Neil Parry, Peter Kim, Bertha García, Xing Li, Colin Macaulay, Grant McFadden, Alexandra Lucas, Robert Zhong	2006	33
17	A secreted high-affinity inhibitor of human TNF from Tanapox virus Proceedings of the National Academy of Sciences ·Craig R. Brunetti, Natalia Zambrano Luna, Rajkumari Singh, Jing Qin, John W. Barrett, Aubry Tardivel, Pascal Schneider, Karim Essani, Grant McFadden	2003	49
18	CHEMOKINE-BINDING VIRAL PROTEIN M-T7 PREVENTS CHRONIC REJECTION IN RAT RENAL ALLOGRAFTS Transplantation ·Eric L.R. Bédard, Peter Kim, Jifu Jiang, Neil Parry, Liying Liu, Hao Wang, Bertha García, Xing Li, Grant McFadden, Alexandra Lucas, Robert Zhong	2003	35
19	Characterization of a Monoclonal Antibody Specific for a Novel Primate Cell Surface Marker with Distinct Biochemical Properties on Human Erythroleukemia and Myeloid Cell Lines PubMed ·M. HOLSCHBACH, Grant McFadden	2002	0
20	The viral anti-inflammatory chemokine-binding protein M-T7 reduces intimal hyperplasia after vascular injury Journal of Clinical Investigation ·Liying Liu, Alshad S. Lalani, Erbin Dai, Bruce T. Seet, C. V. Branson, Raj Kumar Singh, Supriya Aggarwal, Grant McFadden, K.V. Krasnobaev	2000	81

About Grant McFadden

Grant McFadden is a scholar working on Virology, Genetics, Immunology, Epidemiology and Animal Science and Zoology, having authored 347 papers that have together received 18.9k indexed citations. Recurring topics across this work include Virus-based gene therapy research (197 papers), Herpesvirus Infections and Treatments (151 papers), Poxvirus research and outbreaks (129 papers), interferon and immune responses (61 papers), Animal Virus Infections Studies (37 papers), Immunotherapy and Immune Responses (37 papers), CAR-T cell therapy research (35 papers) and Plant Virus Research Studies (29 papers). The work is most often cited by research in Virology (5.8k citations), Immunology (5.6k citations), Genetics (7.1k citations), Epidemiology (7.1k citations) and Animal Science and Zoology (1.5k citations). Grant McFadden has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Chris Upton, Masmudur M. Rahman, John W. Barrett, Morgan Sheng, Helen Everett, Michael E. Greenberg, B. Brett Finlay, Masmudur M. Rahman, Karen Mossman and James B. Johnston. Their work appears in journals such as Journal of Virology, Virology, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact